This article provides a comprehensive comparative analysis of lipidomic profiles in Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D), synthesizing recent findings from clinical studies to elucidate distinct pathophysiological...
This article provides a comprehensive guide for researchers and drug development professionals tackling the central challenge in lipidomics: achieving comprehensive coverage of complex lipidomes.
This article provides a systematic overview of modern strategies for lipid species identification using tandem mass spectrometry (MS/MS).
This article provides a comprehensive guide for researchers and drug development professionals on managing batch effects in lipidomics data analysis.
Lipidomic analysis of plasma and serum is crucial for discovering biomarkers and understanding disease mechanisms in biomedical research.
Untargeted lipidomics provides a powerful, unbiased approach for discovering novel lipid biomarkers and pathways, but its potential is heavily dependent on rigorous quality control to ensure data reliability and reproducibility.
Lipidomics, the large-scale study of lipid pathways and networks, is increasingly recognized for its role in precision health, with profiles often predicting disease onset years earlier than genetic markers.
This article provides a comprehensive guide for researchers and drug development professionals on standardizing lipidomic protocols for clinical samples.
Lipidomics has emerged as a powerful tool for discovering biomarkers that reflect real-time metabolic states in diseases ranging from cancer to inflammatory disorders.
This article provides a detailed guide to lipidomics workflows, tailored for researchers, scientists, and drug development professionals.